Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease

Gut

Volumn 65, Issue 12, 2016, Pages 1930-1937

  Uhde, Melanie ^a   Ajamian, Mary ^a   Caio, Giacomo ^b   De Giorgio, Roberto ^b   Indart, Alyssa ^a   Green, Peter H ^a   Verna, Elizabeth C ^a   Volta, Umberto ^b   Alaedini, Armin ^a  

^a Department of Medicine   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CELIAC DISEASE; GUT INFLAMMATION; INTESTINAL BARRIER FUNCTION; INTESTINAL EPITHELIUM

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; FATTY ACID BINDING PROTEIN 2; FLAGELLIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE BINDING PROTEIN; ACUTE PHASE PROTEIN; AUTOANTIBODY; BIOLOGICAL MARKER; CARRIER PROTEIN; FATTY ACID BINDING PROTEIN; GLUTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CELIAC DISEASE; CELL DAMAGE; CEREAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOREGULATION; INTESTINE CELL; MAJOR CLINICAL STUDY; MALE; NONCELIAC WHEAT SENSITIVITY; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC IMMUNE ACTIVATION; WHEAT ALLERGY; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PREDICTIVE VALUE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SMALL INTESTINE; WHEAT HYPERSENSITIVITY;

ACUTE-PHASE PROTEINS; ADULT; ANTIGENS, CD14; AUTOANTIBODIES; BIOMARKERS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELIAC DISEASE; FATTY ACID-BINDING PROTEINS; FEMALE; FLAGELLIN; GLUTENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES; WHEAT HYPERSENSITIVITY;

EID: 84979521173     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-311964     Document Type: Article

References (47)

1. Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr 2014;168:272-8.
2. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003;61:105-17.
3. Sollid LM, Jabri B. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol 2011;23:732-8.
4. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006;131:1981-2002.
5. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012;107:1898-906.
6. Volta U, Bardella MT, Calabrò A, et al. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med 2014;12:85.
7. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011;106:508-14.
8. Peters SL, Biesiekierski JR, Yelland GW, et al. Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity-an exploratory clinical study. Aliment Pharmacol Ther 2014;39:1104-12.
9. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52.
10. Fasano A, Sapone A, Zevallos V, et al. Nonceliac gluten sensitivity. Gastroenterology 2015;148:1195-204.
11. Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol 2015;135:1099-106.
12. Di Sabatino A, Volta U, Salvatore C, et al. Small amounts of gluten in subjects with suspected nonceliac gluten sensitivity: a randomized, double-blind, placebo-controlled, cross-over trial. Clin Gastroenterol Hepatol 2015;13:1604-12.
13. Junker Y, Zeissig S, Kim SJ, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 2012;209:2395-408.
14. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320-8.
15. Volta U, Tovoli F, Cicola R, et al. Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol 2012;46:680-5.
16. Sapone A, Lammers KM, Casolaro V, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med 2011;9:23.
17. Brottveit M, Beitnes AC, Tollefsen S, et al. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol 2013;108:842-50.
18. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010;6:e1001052.
19. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012;30:149-73.
20. Catassi C, Elli L, Bonaz B, et al. Diagnosis of non-celiac gluten sensitivity (NCGS): the Salerno experts' criteria. Nutrients 2015;7:4966-77.
21. Caio G, Volta U, Tovoli F, et al. Effect of gluten free diet on immune response to gliadin in patients with non-celiac gluten sensitivity. BMC Gastroenterol 2014;14:26.
22. Volta U, Caio G, De Giorgio R, et al. Non-celiac gluten sensitivity: a work-in-progress entity in the spectrum of wheat-related disorders. Best Pract Res Clin Gastroenterol 2015;29:477-91.
23. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-76.
24. Moeller S, Canetta PA, Taylor AK, et al. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. PLoS ONE 2014;9: e94677.
25. Lau NM, Green PH, Taylor AK, et al. Markers of celiac disease and gluten sensitivity in children with autism. PLoS ONE 2013;8:e66155.
26. Huebener S, Tanaka CK, Uhde M, et al. Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res 2015;14:503-11.
27. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005;3:36-46.
28. Barclay GR. Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog Clin Biol Res 1995;392:263-72.
29. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
30. Chen Z, Jalabi W, Shpargel KB, et al. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci 2012;32:11706-15.
31. Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 2012;10:655-66.
32. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.
33. Pelsers MM, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 2003;36:529-35.
34. Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011;141:1220-30.
35. Sacchettini JC, Hauft SM, Van Camp SL, et al. Developmental and structural studies of an intracellular lipid binding protein expressed in the ileal epithelium. J Biol Chem 1990;265:19199-207.
36. Adriaanse MP, Tack GJ, Passos VL, et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 2013;37:482-90.
37. Hunt PW, Sinclair E, Rodriguez B, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis 2014;210:1228-38.
38. Shahbazkhani B, Sadeghi A, Malekzadeh R, et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo-controlled trial. Nutrients 2015;7:4542-54.
39. Derikx JP, Vreugdenhil AC, Van den Neucker AM, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009;43:727-33.
40. Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004;304:242-8.
41. Kiesslich R, Goetz M, Angus EM, et al. Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 2007;133:1769-78.
42. Lanzavecchia A, Bernasconi N, Traggiai E, et al. Understanding and making use of human memory B cells. Immunol Rev 2006;211:303-9.
43. Capolunghi F, Rosado MM, Sinibaldi M, et al. Why do we need IgM memory B cells? Immunol Lett 2013;152:114-20.
44. Bailey M, Haverson K, Miller B, et al. Effects of infection with transmissible gastroenteritis virus on concomitant immune responses to dietary and injected antigens. Clin Diagn Lab Immunol 2004;11:337-43.
45. Ehrenstein MR, Notley CA. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 2010;10:778-86.
46. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011;106:1333-9.
47. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007;5:445-50.